Page last updated: 2024-10-22

acetazolamide and Cavernous Angioma, Central Nervous System

acetazolamide has been researched along with Cavernous Angioma, Central Nervous System in 1 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dudeck, O1
van Velthoven, V1
Schumacher, M1
Klisch, J1

Reviews

1 review available for acetazolamide and Cavernous Angioma, Central Nervous System

ArticleYear
Development of a complex dural arteriovenous fistula next to a cerebellar developmental venous anomaly after resection of a brainstem cavernoma. Case report and review of the literature.
    Journal of neurosurgery, 2004, Volume: 100, Issue:2

    Topics: Acetazolamide; Adolescent; Brain Stem Neoplasms; Central Nervous System Vascular Malformations; Cere

2004